Question to the Department of Health and Social Care:

To ask Her Majesty’s Government why NHS England has decided to restrict hepatitis C treatment, with providers subject to a financial penalty if they do not keep within specified numbers, despite those treatments being approved as cost-effective by NICE.

The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.

NHS England is funding providers to treat patients at the rate outlined in NICE’s guidance, Technology Appraisals 363, 364 and 365, apportioned to local ODNs based on local health needs. Copies of these Technology Appraisals are attached.